Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

symptoms

- PMLiVE

Celgene signs $500m antibody deal with Sutro

Joins list of companies with interest in antibody-drug conjugates

- PMLiVE

Celgene wins 2012 PMEA for excellence in ongoing brand management

Also receives recognition for internal capability development and orphan drug Vidaza

- PMLiVE

Patient Engagement – the Way Forward

We asked Melanie Kirk to tell us – in bite-sized chunks – how to build an integrated campaign for the patient

Celgene’s Abraxane receives FDA approval in lung cancer

Adds to current breast cancer indication

Janssen adds Astellas JAK inhibitor to its immunology portfolio

Licenses oral rheumatoid arthritis and psoriasis candidate ASP015K

Novartis drug effective in hard-to-treat psoriasis

Secukinumab to commence phase III trials

- PMLiVE

Interview: Sam Pearce, Celgene

The general manager of Celgene UK and Ireland explains to Liz Wells how her entrepreneurial spirit fits well with this fast-expanding biotech

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links